SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (521)2/18/1998 2:37:00 AM
From: Xenafan  Read Replies (1) | Respond to of 9523
 
Abbot Labs has announced a split for holders as
of May 1. Abbot and Pfizer look like similar
companies. Abbot is suppose to have a new super
pain killer in development. PFE also has much
R&D. They both look like they have great potential.

The question: (Try to be objective in your replies)

If you had only enough money to buy 100 shares of
one of the companies, which one?



To: BigKNY3 who wrote (521)2/19/1998 2:22:00 AM
From: roger m  Respond to of 9523
 
Actually the last 2 splits were announced at the 90 level and then the 110+ level.I think the trend is to split at higher levels now. Maybe at 130 but then a 3 for 1 split like WLA did.But first let's see it get to 130 if it can do that.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News